Skip to main content
Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
339.57
-0.61 (-0.18%)
At close: Apr 28, 2026, 4:00 PM EDT
337.27
-2.30 (-0.68%)
After-hours: Apr 28, 2026, 4:35 PM EDT

Amgen Revenue

In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth. Amgen had revenue of $9.87B in the quarter ending December 31, 2025, with 8.58% growth.

Revenue (ttm)
$36.75B
Revenue Growth
+9.95%
P/S Ratio
4.97
Revenue / Employee
$1,166,698
Employees
31,500
Market Cap
183.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202536.75B3.33B9.95%
Dec 31, 202433.42B5.23B18.57%
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 96.36B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Novartis AG 56.67B
Sanofi 54.85B
Novo Nordisk 48.59B
Revenue Rankings

AMGN News

More News